Aimei Health Technology - AFJK Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.79
▼ -0.39 (-4.77%)

This chart shows the closing price for AFJK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aimei Health Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AFJK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AFJK

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Aimei Health Technology in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $7.79.

This chart shows the closing price for AFJK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 contributing investment analysts is to sell stock in Aimei Health Technology.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/25/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
11/19/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/13/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/7/2025Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
10/8/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
9/27/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.11 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2025
  • 2 very positive mentions
  • 25 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/5/2025

Current Sentiment

  • 2 very positive mentions
  • 25 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Aimei Health Technology logo
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Read More

Today's Range

Now: $7.79
Low: $6.75
High: $8.02

50 Day Range

MA: $11.37
Low: $7.79
High: $21.80

52 Week Range

Now: $7.79
Low: $6.75
High: $41.80

Volume

3,621 shs

Average Volume

32,741 shs

Market Capitalization

$47.67 million

P/E Ratio

37.10

Dividend Yield

N/A

Beta

0.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Aimei Health Technology?

The following sell-side analysts have issued research reports on Aimei Health Technology in the last twelve months: Weiss Ratings.
View the latest analyst ratings for AFJK.

What is the current price target for Aimei Health Technology?

0 Wall Street analysts have set twelve-month price targets for Aimei Health Technology in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aimei Health Technology in the next year.
View the latest price targets for AFJK.

What is the current consensus analyst rating for Aimei Health Technology?

Aimei Health Technology currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe AFJK will underperform the market and that investors should sell shares of Aimei Health Technology.
View the latest ratings for AFJK.

What other companies compete with Aimei Health Technology?

How do I contact Aimei Health Technology's investor relations team?

The company's listed phone number is 34-67-803-5200. Learn More about contacing Aimei Health Technology investor relations.